Literature DB >> 30688746

68Ga-PSMA-11 PET/MR Can Be False Positive in Normal Prostatic Tissue.

Daniela A Ferraro1, Niels J Rupp2, Olivio F Donati3, Michael Messerli1, Daniel Eberli4, Irene A Burger1.   

Abstract

Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in the cytosol of normal prostate tissue and highly overexpressed on the membrane of prostate cancer, therefore increasingly used to image prostate cancer. We report a case of a 65-year-old man with two focal PSMA-positive areas on a Ga-PSMA-11 PET/MR, one corresponding to a prostate carcinoma (Gleason score 4 + 3) and another region without any evidence of malignancy, but with corresponding high PSMA-expression on immunohistochemistry.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30688746     DOI： 10.1097/RLU.0000000000002473

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  5 in total

1.  In Vivo Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification.

Authors:  Jinghang Xie; Meghan A Rice; Zixin Chen; Yunfeng Cheng; En-Chi Hsu; Min Chen; Guosheng Song; Liyang Cui; Kaixiang Zhou; Jessa B Castillo; Chiyuan A Zhang; Bin Shen; Frederick T Chin; Christian A Kunder; James D Brooks; Tanya Stoyanova; Jianghong Rao
Journal:  Cancer Res       Date:  2021-02-26       Impact factor: 13.312

2.  A Pilot Study of 18F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions.

Authors:  Yachao Liu; Hongkai Yu; Jiajin Liu; Xiaojun Zhang; Mu Lin; Holger Schmidt; Jiangping Gao; Baixuan Xu
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

3.  Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study

Authors:  Lebriz Uslu-Beşli; Barış Bakır; Sertaç Asa; Ekrem Güner; Çetin Demirdağ; Onur Erdem Şahin; Emre Karayel; Muhammet Sait Sağer; Haluk Burçak Sayman; Kerim Sönmezoğlu
Journal:  Mol Imaging Radionucl Ther       Date:  2019-09-06

4.  Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study.

Authors:  Daniel Eberli; Irene A Burger; Daniela A Ferraro; Anton S Becker; Benedikt Kranzbühler; Iliana Mebert; Anka Baltensperger; Konstantinos G Zeimpekis; Hannes Grünig; Michael Messerli; Niels J Rupp; Jan H Rueschoff; Ashkan Mortezavi; Olivio F Donati; Marcelo T Sapienza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-23       Impact factor: 9.236

5.  Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68Ga-PSMA PET/CT: a real-world study.

Authors:  Jianhua Jiao; Fei Kang; Jingliang Zhang; Zhiyong Quan; Weihong Wen; Xiaohu Zhao; Shuaijun Ma; Peng Wu; Fa Yang; Wei Guo; Xiaojian Yang; Jianlin Yuan; Yongquan Shi; Jing Wang; Weijun Qin
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.